Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease

被引：0
|
作者：
Donald P. Tashkin
Nicola A. Hanania
Joe McGinty
Kimberly Denis-Mize
Imtiaz Chaudry
机构：
[1] David Geffen School of Medicine at UCLA,Division of Pulmonary and Critical Care Medicine
[2] Baylor College of Medicine,Division of Pulmonary and Critical Care Medicine
[3] Dey Pharma LP,undefined
来源：
Advances in Therapy | 2009年 / 26卷
关键词：
chronic obstructive pulmonary disease; formoterol; long-acting beta; agonist; maintenance therapy; nebulization; tiotropium;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1024 / 1034
页数：10
相关论文
共 50 条
  • [21] Cost Effectiveness of Budesonide/Formoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary DiseaseAustralian, Canadian and Swedish Healthcare Perspectives
    Nicole Mittmann
    Paul Hernandez
    Carl Mellström
    Lance Brannman
    Tobias Welte
    PharmacoEconomics, 2011, 29 : 403 - 414
  • [22] Tiotropium in Chronic Obstructive Pulmonary Disease Reply
    Tashkin, Donald P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (02): : 187 - 187
  • [23] Tiotropium in the management of chronic obstructive pulmonary disease
    Rees, PJ
    EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (02) : 205 - 206
  • [24] Tiotropium: A bronchodilator for chronic obstructive pulmonary disease
    Somand, H
    Remington, TL
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (09) : 1467 - 1475
  • [25] Development of tiotropium inhalation formulations for the treatment of chronic obstructive pulmonary disease
    Oh N.M.
    Oh K.T.
    Youn Y.S.
    Lee D.-K.
    Cha K.-H.
    Lee E.S.
    Journal of Pharmaceutical Investigation, 2013, 43 (1) : 71 - 74
  • [26] Safety and efficacy of concomitant treatment with nebulized formoterol and tiotropium in COPD
    Tashkin, Donald P.
    Littner, Michael R.
    Andrews, Charles P.
    Rinehart, Mike
    Denis-Mize, Kimberly
    CHEST, 2007, 132 (04) : 531S - 532S
  • [27] Effect of formoterol, tiotropium, and their combination in patients with acute exacerbation of chronic obstructive pulmonary disease: A pilot study
    Di Marco, Fabiano
    Verga, Massimo
    Santus, Pierachille
    Morelli, Nicoletta
    Cazzola, Mario
    Centanni, Stefano
    RESPIRATORY MEDICINE, 2006, 100 (11) : 1925 - 1932
  • [28] Olodaterol plus tiotropium bromide for the treatment of chronic obstructive pulmonary disease
    Cazzola, Mario
    Rogliani, Paola
    Ora, Josuel
    Matera, Maria Gabriella
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (05) : 529 - 539
  • [29] Effect of Tiotropium on eye findings in the treatment of chronic obstructive pulmonary disease
    Aksoy, Hayriye Bektas
    Koc, Hakan
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [30] Budesonide/formoterol in chronic obstructive pulmonary disease
    Reynolds, NA
    Perry, CM
    Keating, GM
    DRUGS, 2004, 64 (04) : 431 - 441
12345